trial
as of 2026-07-01Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
NCTId NCT03790085
at a glance
Early Phase 1 · Unknown
Enrollment 2,700 (estimated)
Sponsored by Tianjin Medical University General Hospital
Primary completion 2020-06-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Early Phase 1
Status
Unknown
Enrollment
2,700 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2018-09-01
Primary completion
2020-06-30
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Sponsors
Tianjin Medical University General HospitalLead Sponsor
Shanghai Mental Health CenterCollaborator
Nanjing Medical UniversityCollaborator
Tianjin Anding HospitalCollaborator
Harbin First Specialist HospitalCollaborator
Anhui Mental Health CenterCollaborator
Wuhan Psychiatric HospitalCollaborator
Wenzhou Seventh People's HospitalCollaborator
Investigators
1
Chunshui Yu, PhDPrincipal Investigator
Sites
1 total
Tianjin, China
Facts & assertions
4 sourced
Enrollment
2,700
Phase
EARLY_PHASE1
Primary Completion Date
2020-06-30
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator
person